Clinical trials referenced in this document:
Documents that mention this clinical trial
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
Funding for this research was provided by:
The Duke Endowment
Received: 8 September 2022
Accepted: 19 November 2022
First Online: 3 December 2022
: The Duke University Health Sciences Institutional Review Board approved the study. We created a separate protocol for the acceptability and feasibility study and had different study team members interact with program participants than in the pilot study to reduce social desirability bias. Participants provided their oral informed consent for participating in the IDIs.
: Not applicable.
: The authors declare that they have no competing interests.